During the past decade, UOC Medicina Interna conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UOC Medicina Interna" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "UOC Medicina Interna" are "Crohn's Disease" (2 trials). Many other conditions were trialed in "UOC Medicina Interna" in a lesser frequency.

Most popular intervention types in "UOC Medicina Interna" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Filgotinib" (2 trials), "Placebo" (1 trials) and "Placebo to match filgotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "UOC Medicina Interna" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UOC Medicina Interna". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in UOC Medicina Interna, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UOC Medicina Interna, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".